APO RESEARCH · REPORT
Organ-on-Chip
An organ-on-a-chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-on-a-chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels.
Product & engineering
Understand the product.
An organ-on-a-chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-on-a-chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels.
Selected research
Market Structure
Global Organ-on-Chip Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
An organ-on-a-chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-on-a-chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels.
Global Organ-on-Chip key players include Emulate, TissUse, Hesperos, CN Bio Innovations, Tara Biosystems, etc. Global top five manufacturers hold a share about 55%.
North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific, both have a share about 50 percent.
Read the full market overview
In terms of product, Liver-on-a-chip is the largest segment, with a share about 30%. And in terms of application, the largest application is Pharmaceutical & Biotechnology Companies, followed by Academic & Research Institutes.
The report provides an overview of the global Organ-on-Chip market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Organ-on-Chip and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Organ-on-Chip sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Organ-on-Chip market size, projected growth trends, production technologies, key applications, and end-use industries.
Organ-on-Chip Segment by Company
Emulate
TissUse
Hesperos
CN Bio Innovations
Tara Biosystems
Draper Laboratory
Mimetas
Nortis
Micronit Microtechnologies B.V.
Kirkstall
Cherry Biotech SAS
Else Kooi Laboratory
Organ-on-Chip Segment by Type
Brain-on-a-chip
Liver-on-a-chip
Kidney-on-a-chip
Lung-on-a-chip
Heart-on-a-chip
Intestine-on-a-chip
Others
Organ-on-Chip Segment by End Users
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Cosmetics Industry
Other End Users
Organ-on-Chip Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Organ-on-Chip market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Organ-on-Chip and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Organ-on-Chip.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Organ-on-Chip market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Organ-on-Chip industry.
Chapter 3: Detailed analysis of Organ-on-Chip market competition landscape. Including Organ-on-Chip manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Organ-on-Chip by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Organ-on-Chip in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Brain-on-a-chip
- Liver-on-a-chip
- Kidney-on-a-chip
- Lung-on-a-chip
- Heart-on-a-chip
- Intestine-on-a-chip
- Others
Applications
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Cosmetics Industry
- Other End Users
Companies covered
- Emulate
- TissUse
- Hesperos
- CN Bio Innovations
- Tara Biosystems
- Draper Laboratory
- Mimetas
- Nortis
- Micronit Microtechnologies B.V.
- Kirkstall
- Cherry Biotech SAS
- Else Kooi Laboratory
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Organ-on-Chip Production Value Estimates and Forecasts (2021-2032)
- 1.2.2 Global Organ-on-Chip Production Capacity Estimates and Forecasts (2021-2032)
- 1.2.3 Global Organ-on-Chip Production Estimates and Forecasts (2021-2032)
- 1.2.4 Global Organ-on-Chip Market Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Global Organ-on-Chip Market Dynamics
- 2.1 Organ-on-Chip Industry Trends
- 2.2 Organ-on-Chip Industry Drivers
- 2.3 Organ-on-Chip Industry Opportunities and Challenges
- 2.4 Organ-on-Chip Industry Restraints
3 Organ-on-Chip Market by Manufacturers
- 3.1 Global Organ-on-Chip Production Value by Manufacturers (2021-2026)
- 3.2 Global Organ-on-Chip Production by Manufacturers (2021-2026)
- 3.3 Global Organ-on-Chip Average Price by Manufacturers (2021-2026)
- 3.4 Global Organ-on-Chip Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Organ-on-Chip Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Organ-on-Chip Manufacturers, Product Type & Application
- 3.7 Global Organ-on-Chip Manufacturers Established Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Organ-on-Chip Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Organ-on-Chip Players Market Share by Production Value in 2025
- 3.8.3 2025 Organ-on-Chip Tier 1, Tier 2, and Tier 3
4 Organ-on-Chip Market by Type
- 4.1 Organ-on-Chip Type Introduction
- 4.1.1 Brain-on-a-chip
- 4.1.2 Liver-on-a-chip
- 4.1.3 Kidney-on-a-chip
- 4.1.4 Lung-on-a-chip
- 4.1.5 Heart-on-a-chip
- 4.1.6 Intestine-on-a-chip
- 4.1.7 Others
- 4.2 Global Organ-on-Chip Production by Type
- 4.2.1 Global Organ-on-Chip Production by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Organ-on-Chip Production by Type (2021-2032)
- 4.2.3 Global Organ-on-Chip Production Market Share by Type (2021-2032)
- 4.3 Global Organ-on-Chip Production Value by Type
- 4.3.1 Global Organ-on-Chip Production Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Organ-on-Chip Production Value by Type (2021-2032)
- 4.3.3 Global Organ-on-Chip Production Value Market Share by Type (2021-2032)
5 Organ-on-Chip Market by Application
- 5.1 Organ-on-Chip Application Introduction
- 5.1.1 Pharmaceutical and Biotechnology Companies
- 5.1.2 Academic and Research Institutes
- 5.1.3 Cosmetics Industry
- 5.1.4 Other End Users
- 5.2 Global Organ-on-Chip Production by Application
- 5.2.1 Global Organ-on-Chip Production by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Organ-on-Chip Production by Application (2021-2032)
- 5.2.3 Global Organ-on-Chip Production Market Share by Application (2021-2032)
- 5.3 Global Organ-on-Chip Production Value by Application
- 5.3.1 Global Organ-on-Chip Production Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Organ-on-Chip Production Value by Application (2021-2032)
- 5.3.3 Global Organ-on-Chip Production Value Market Share by Application (2021-2032)
6 Company Profiles
- 6.1 Emulate
- 6.1.1 Emulate Company Information
- 6.1.2 Emulate Business Overview
- 6.1.3 Emulate Organ-on-Chip Production, Value and Gross Margin (2021-2026)
- 6.1.4 Emulate Organ-on-Chip Product Portfolio
- 6.1.5 Emulate Recent Developments
- 6.2 TissUse
- 6.2.1 TissUse Company Information
- 6.2.2 TissUse Business Overview
- 6.2.3 TissUse Organ-on-Chip Production, Value and Gross Margin (2021-2026)
- 6.2.4 TissUse Organ-on-Chip Product Portfolio
- 6.2.5 TissUse Recent Developments
- 6.3 Hesperos
- 6.3.1 Hesperos Company Information
- 6.3.2 Hesperos Business Overview
- 6.3.3 Hesperos Organ-on-Chip Production, Value and Gross Margin (2021-2026)
- 6.3.4 Hesperos Organ-on-Chip Product Portfolio
- 6.3.5 Hesperos Recent Developments
- 6.4 CN Bio Innovations
- 6.4.1 CN Bio Innovations Company Information
- 6.4.2 CN Bio Innovations Business Overview
- 6.4.3 CN Bio Innovations Organ-on-Chip Production, Value and Gross Margin (2021-2026)
- 6.4.4 CN Bio Innovations Organ-on-Chip Product Portfolio
- 6.4.5 CN Bio Innovations Recent Developments
- 6.5 Tara Biosystems
- 6.5.1 Tara Biosystems Company Information
- 6.5.2 Tara Biosystems Business Overview
- 6.5.3 Tara Biosystems Organ-on-Chip Production, Value and Gross Margin (2021-2026)
- 6.5.4 Tara Biosystems Organ-on-Chip Product Portfolio
- 6.5.5 Tara Biosystems Recent Developments
- 6.6 Draper Laboratory
- 6.6.1 Draper Laboratory Company Information
- 6.6.2 Draper Laboratory Business Overview
- 6.6.3 Draper Laboratory Organ-on-Chip Production, Value and Gross Margin (2021-2026)
- 6.6.4 Draper Laboratory Organ-on-Chip Product Portfolio
- 6.6.5 Draper Laboratory Recent Developments
- 6.7 Mimetas
- 6.7.1 Mimetas Company Information
- 6.7.2 Mimetas Business Overview
- 6.7.3 Mimetas Organ-on-Chip Production, Value and Gross Margin (2021-2026)
- 6.7.4 Mimetas Organ-on-Chip Product Portfolio
- 6.7.5 Mimetas Recent Developments
- 6.8 Nortis
- 6.8.1 Nortis Company Information
- 6.8.2 Nortis Business Overview
- 6.8.3 Nortis Organ-on-Chip Production, Value and Gross Margin (2021-2026)
- 6.8.4 Nortis Organ-on-Chip Product Portfolio
- 6.8.5 Nortis Recent Developments
- 6.9 Micronit Microtechnologies B.V.
- 6.9.1 Micronit Microtechnologies B.V. Company Information
- 6.9.2 Micronit Microtechnologies B.V. Business Overview
- 6.9.3 Micronit Microtechnologies B.V. Organ-on-Chip Production, Value and Gross Margin (2021-2026)
- 6.9.4 Micronit Microtechnologies B.V. Organ-on-Chip Product Portfolio
- 6.9.5 Micronit Microtechnologies B.V. Recent Developments
- 6.10 Kirkstall
- 6.10.1 Kirkstall Company Information
- 6.10.2 Kirkstall Business Overview
- 6.10.3 Kirkstall Organ-on-Chip Production, Value and Gross Margin (2021-2026)
- 6.10.4 Kirkstall Organ-on-Chip Product Portfolio
- 6.10.5 Kirkstall Recent Developments
- 6.11 Cherry Biotech SAS
- 6.11.1 Cherry Biotech SAS Company Information
- 6.11.2 Cherry Biotech SAS Business Overview
- 6.11.3 Cherry Biotech SAS Organ-on-Chip Production, Value and Gross Margin (2021-2026)
- 6.11.4 Cherry Biotech SAS Organ-on-Chip Product Portfolio
- 6.11.5 Cherry Biotech SAS Recent Developments
- 6.12 Else Kooi Laboratory
- 6.12.1 Else Kooi Laboratory Company Information
- 6.12.2 Else Kooi Laboratory Business Overview
- 6.12.3 Else Kooi Laboratory Organ-on-Chip Production, Value and Gross Margin (2021-2026)
- 6.12.4 Else Kooi Laboratory Organ-on-Chip Product Portfolio
- 6.12.5 Else Kooi Laboratory Recent Developments
7 Global Organ-on-Chip Production by Region
- 7.1 Global Organ-on-Chip Production by Region: 2021 VS 2025 VS 2032
- 7.2 Global Organ-on-Chip Production by Region (2021-2032)
- 7.2.1 Global Organ-on-Chip Production by Region (2021-2026)
- 7.2.2 Global Organ-on-Chip Production Forecast by Region (2027-2032)
- 7.3 Global Organ-on-Chip Production by Region: 2021 VS 2025 VS 2032
- 7.4 Global Organ-on-Chip Production Value by Region (2021-2032)
- 7.4.1 Global Organ-on-Chip Production Value by Region (2021-2026)
- 7.4.2 Global Organ-on-Chip Production Value by Region (2027-2032)
- 7.5 Global Organ-on-Chip Market Price Analysis by Region (2021-2032)
- 7.6 Regional Production Value Trends (2021-2032)
- 7.6.1 North America Organ-on-Chip Production Value (2021-2032)
- 7.6.2 Europe Organ-on-Chip Production Value (2021-2032)
- 7.6.3 Asia-Pacific Organ-on-Chip Production Value (2021-2032)
- 7.6.4 South America Organ-on-Chip Production Value (2021-2032)
- 7.6.5 Middle East & Africa Organ-on-Chip Production Value (2021-2032)
8 Global Organ-on-Chip Consumption by Region
- 8.1 Global Organ-on-Chip Consumption by Region: 2021 VS 2025 VS 2032
- 8.2 Global Organ-on-Chip Consumption by Region (2021-2032)
- 8.2.1 Global Organ-on-Chip Consumption by Region (2021-2026)
- 8.2.2 Global Organ-on-Chip Consumption by Region (2027-2032)
- 8.3 North America
- 8.3.1 North America Organ-on-Chip Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3.2 North America Organ-on-Chip Consumption by Country (2021-2032)
- 8.3.3 U.S.
- 8.3.4 Canada
- 8.3.5 Mexico
- 8.4 Europe
- 8.4.1 Europe Organ-on-Chip Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.4.2 Europe Organ-on-Chip Consumption by Country (2021-2032)
- 8.4.3 Germany
- 8.4.4 France
- 8.4.5 U.K.
- 8.4.6 Italy
- 8.4.7 Netherlands
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Organ-on-Chip Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.5.2 Asia Pacific Organ-on-Chip Consumption by Country (2021-2032)
- 8.5.3 China
- 8.5.4 Japan
- 8.5.5 South Korea
- 8.5.6 Southeast Asia
- 8.5.7 India
- 8.5.8 Australia
- 8.6 South America
- 8.6.1 South America Organ-on-Chip Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.6.2 South America Organ-on-Chip Consumption by Country (2021-2032)
- 8.6.3 Brazil
- 8.6.4 Argentina
- 8.6.5 Chile
- 8.6.6 Colombia
- 8.7 Middle East & Africa
- 8.7.1 Middle East & Africa Organ-on-Chip Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.7.2 Middle East & Africa Organ-on-Chip Consumption by Country (2021-2032)
- 8.7.3 Egypt
- 8.7.4 South Africa
- 8.7.5 Israel
- 8.7.6 Türkiye
- 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
- 9.1 Organ-on-Chip Value Chain Analysis
- 9.1.1 Organ-on-Chip Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Organ-on-Chip Production Mode & Process
- 9.2 Organ-on-Chip Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Organ-on-Chip Distributors
- 9.2.3 Organ-on-Chip Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst